Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in chronic lymphocytic leukemia (phase 2, France)
2011-000792-14Phase 2Terminated
- Sponsor
- Institut Paoli-Calmettes
- Start
- Apr 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of rituximab in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Institut Paoli-Calmettes. Started Apr 2011; status: terminated.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2011-000792-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000792-14.